High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril.
about
Induction of a reduction in haemoglobin concentration by enalapril in stable, moderate heart failure: a double blind studyCandesartan cilexetil: an angiotensin II receptor blocker.Efficacy and safety of angiotensin II receptor blockers in elderly patients with mild to moderate hypertension.Improving prognosis estimation in patients with heart failure and the cardiorenal syndromeMechanisms and treatment of anemia in chronic heart failure.Erythropoietin resistance in the treatment of the anemia of chronic renal failure.Heart failure and anemia: mechanisms and pathophysiology.IGF-1 is an independent risk factor for anemia in diabetic pre-dialysis patients.Erythropoietin and the heart: facts and perspectives.A randomized clinical trial to determine the effect of angiotensin inhibitors reduction on creatinine clearance and haemoglobin in heart failure patients with chronic kidney disease and anaemia.Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteersCardio-renal anemia syndrome.Efficacy of enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation.Management of anemia and iron deficiency in heart failure.Pharmacotherapy in congestive heart failure: ACE inhibitors and anemia in congestive heart failure.Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation.
P2860
Q33611333-ECC5F32A-A93A-4622-8ADD-8759173CDA03Q33814549-06F4A573-7AE1-45F6-B5E6-34330B6E6ED9Q34286750-D880EAEC-368E-44B9-B488-D915A2B84929Q35020305-919DE890-3C10-4F05-9F4E-38B27F709338Q35911432-A91C650D-22C8-4EB0-BB33-379104A4E1F8Q36558711-DA7B83D3-873C-450E-86BF-E810B795DB60Q37072561-16AD6C9D-6F7F-43A4-908B-2BBC04A55E22Q37205471-32C238C2-618C-474A-BDD0-E12AF85FB874Q37798565-6AF81145-E308-42E7-B9DE-8F060AB69BCBQ38231440-E311B802-1F82-4405-A982-0826525122D2Q41212035-3A76910B-CA83-412D-98F0-E0440607AAA3Q42207303-AC3EC7E3-B73F-4B56-A5DE-6CC8F5AD05B7Q42434368-0E214B28-FDAF-438C-88E5-A22BF43BDB0CQ42547830-5A913E91-C890-48F1-A7D8-1EEC7624F385Q42824239-3B057D26-4C43-41D7-932C-AFE5923D6FDEQ44889483-0913AD1D-A309-40BE-8A77-4EE820D3CA5DQ54054674-A476E579-6282-497F-A953-6434D9E70800
P2860
High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
High serum erythropoietin leve ...... heart failure with enalapril.
@en
High serum erythropoietin leve ...... heart failure with enalapril.
@nl
type
label
High serum erythropoietin leve ...... heart failure with enalapril.
@en
High serum erythropoietin leve ...... heart failure with enalapril.
@nl
prefLabel
High serum erythropoietin leve ...... heart failure with enalapril.
@en
High serum erythropoietin leve ...... heart failure with enalapril.
@nl
P2093
P2860
P1476
High serum erythropoietin leve ...... heart failure with enalapril.
@en
P2093
Fyhrquist F
Honkanen T
Karppinen K
Rosenlöf K
Saijonmaa O
P2860
P304
P356
10.1111/J.1365-2796.1989.TB01390.X
P407
P577
1989-10-01T00:00:00Z